Alzchem Group AG receives strong support from shareholders at Annual General Meeting; dividend increase to EUR 1.20 per share approved Trostberg, May 7, 2024 – At today’s virtual Annual General Meeting, the Management Board and Supervisory Board once again received strong approval from the shareholders of Alzchem Group AG for their direction of th [ … ]

Alzchem Group AG receives strong support from shareholders at Annual General Meeting; dividend increase to EUR 1.20 per share approved Trostberg, May 7, 2024 – At today’s virtual Annual General Meeting, the Management Board and Supervisory Board once again received strong approval from the shareholders of Alzchem Group AG for their direction of th [ … ]

Alzchem Group AG seamlessly builds on strong business performance in 2023 with EBITDA growth of 31.7% in first quarter 2024 Result for the period increases significantly by 58.7% to EUR 12.2 million Strong free cash flow of EUR 26.6 million Management Board confirms forecasts for the full year 2024 Trostberg, April 30, 2024 – Alzchem Group AG, a [ … ]

Trostberg, 15 March 2024 - Following a Europe-wide selection process, Alzchem Group AG has been awarded an investment grant of EUR 34.4 million by the EU Commission as part of the ASAP ("Act in Support of Ammunition Production") funding instrument. Alzchem Group AG wants to use the funds over an investment period of two and a half years to increase [ … ]

EQS-Media / 11.03.2024 / 11:15 CET/CEST Crearene AG and Alzchem Group AG: Successful addition of creatine to dialysis patient treatments As part of their cooperation, Alzchem Group AG and Crearene AG announced in October 2023 that a clinical study on the use of creatine in dialysis treatments had been launched. The aim is to demonstrate the t [ … ]

Alzchem Group AG: EBITDA increase of 32.4 % to EUR 81.4 million – continuing on the road to success High-growth specialty chemicals business proves to be a key earnings driver and important sales pillar Dividend increase to EUR 1.20 planned Forecast for 2024 envisages rise in sales and EBITDA Trostberg, March 1, 2024 – Alzchem Group AG, a verti [ … ]

EQS-Media / 11.01.2024 / 15:28 CET/CEST Long-Covid: New clinical studies show high efficacy of creatine supplementation  Creatine is a natural, endogenous substance that plays a central role as an energy transporter and buffer in every cell. It is an essential component of cellular energy metabolism and is therefore important for all energy-i [ … ]